Codes & Guidelines

PhRMA represents the nation’s leading biopharmaceutical research companies. Our success in developing and delivering medicines to help patients live longer and healthier lives depends on ethical relationships and behavior. Browse key Codes and Guidelines below, and visit our Resource Library for more.

Responsible Sharing of Information About Medicines

In the era of data-driven medicine, where all parties seek more, not less, information about the safety, effectiveness, and value of treatments, fostering informed communications among all stakeholders is critical.

Read More

For a Healthier U.S.: Methods to Fight Prescription Abuse

We need a balanced approach that ensures appropriate access and use of prescription medicines by patients for legitimate medical needs under the direction and care of a licensed health care professional, but that also reduces the potential for misuse, abuse and diversion.

Read More

PhRMA Principles on Interactions with Patient Organizations

Biopharmaceutical companies share many common interests with patient organizations including a common commitment to patients and shared mission to discover cures and fight disease.

Read More

Code on Interactions With Health Care Professionals

Ethical relationships with healthcare professionals are critical to our mission of helping patients by developing and marketing new medicines.

Read More

PhRMA Principles on Conduct of Clinical Trials

Developing new therapies to treat disease and to improve quality of life is a long and complex process. A critical part of that process is clinical research, the study of a pharmaceutical product in humans.

Read More

Direct to Consumer Advertising Principles

In December 2008, the PhRMA Board of Directors unanimously adopted measures to enhance the PhRMA Guiding Principles on Direct to Consumer Advertisements about Prescription Medicines.

Read More

PhRMA Principles for Payment and Delivery System Reforms

Emerging payment and delivery reforms (often called “alternative payment models” or “value-based payment” designs) hold promise in advancing the efficient delivery of high-quality, personalized care.

Read More

PhRMA Principles for Clinical Trial Data Sharing

Biopharmaceutical companies are committed to enhancing public health through responsible sharing of clinical trial data.

Read More

PhRMA Principles on Clinical Pathway Programs

Health care providers and payers are increasingly turning to clinical pathways as tools to manage the cost of care and promote evidence-based treatment.

Read More

Principles for Value Assessment Frameworks

PhRMA supports the use of sound evidence for informed decision-making in health care.

Read More